{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:15:15Z","timestamp":1790223315138,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015272","name":"Italian Association of Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["R023044MM"],"award-info":[{"award-number":["R023044MM"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tcm.2025.02.006","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T03:12:51Z","timestamp":1739416371000},"page":"328-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Uncovering the role of prokineticin pathway on Epicardial Adipose Tissue (EAT) development and EAT-associated cardiomyopathy"],"prefix":"10.1016","volume":"35","author":[{"given":"Martina","family":"Vincenzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan G.","family":"Nebigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2025.02.006_bib0001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phrs.2017.07.020","article-title":"The epicardium as a source of multipotent adult cardiac progenitor cells: their origin, role and fate","volume":"127","author":"Smits","year":"2018","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.tcm.2025.02.006_bib0002","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.1417232112","article-title":"Adipogenesis and epicardial adipose tissue: a novel fate of the epicardium induced by mesenchymal transformation and PPARgamma activation","volume":"112","author":"Yamaguchi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0003","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.116.022064","article-title":"Insulin-like growth factor 1 receptor-dependent pathway drives epicardial adipose tissue formation after myocardial injury","volume":"135","author":"Zangi","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.006_bib0004","doi-asserted-by":"crossref","first-page":"E771","DOI":"10.1073\/pnas.1610968114","article-title":"Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria","volume":"114","author":"Suffee","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.006_bib0005","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/oby.21059","article-title":"Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease","volume":"23","author":"McAninch","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.tcm.2025.02.006_bib0006","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/j.2040-4603.2017.tb00767.x","article-title":"Role of epicardial adipose tissue in health and disease: A matter of fat?","volume":"7","author":"Gaborit","year":"2017","journal-title":"Compr Physiol"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123618","article-title":"UCP1 expression-associated gene signatures of human epicardial adipose tissue","volume":"4","author":"Chechi","year":"2019","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.006_bib0008","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carpath.2008.02.006","article-title":"Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome","volume":"17","author":"Vural","year":"2008","journal-title":"Cardiovasc Pathol"},{"issue":"20","key":"10.1016\/j.tcm.2025.02.006_bib0009","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.02.006_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijcard.2018.09.089","article-title":"Epicardial adipose tissue and cardiovascular diseases","volume":"278","author":"Ansaldo","year":"2019","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.006_bib0011","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/eurheartj\/ehm564","article-title":"Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women","volume":"29","author":"de Vos","year":"2008","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.tcm.2025.02.006_bib0012","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.tcm.2025.02.006_bib0013","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.12659\/MSM.908111","article-title":"Vasodilator-stimulated phosphoprotein: regulators of adipokines resistin and phenotype conversion of epicardial adipocytes","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.tcm.2025.02.006_bib0014","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacc.2011.01.048","article-title":"Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue","volume":"58","author":"Hirata","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/eci.12186","article-title":"Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients","volume":"44","author":"Agra","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"10.1016\/j.tcm.2025.02.006_bib0016","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0017","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/jc.2007-2579","article-title":"Epicardial adipose tissue as a source of nuclear factor-kappaB and c-jun N-terminal kinase mediated inflammation in patients with coronary artery disease","volume":"94","author":"Baker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.006_bib0018","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jc.2009-1222","article-title":"A secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease","volume":"95","author":"Dutour","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.006_bib0019","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/ATVBAHA.116.307225","article-title":"Local production of fatty acid-binding protein 4 in epicardial\/perivascular fat and macrophages is linked to coronary atherosclerosis","volume":"36","author":"Furuhashi","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.006_bib0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.numecd.2017.05.010","article-title":"Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue","volume":"27","author":"Camarena","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.tcm.2025.02.006_bib0021","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjcard.2008.04.002","article-title":"Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography","volume":"102","author":"Gorter","year":"2008","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0022","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1038\/s41598-018-21911-y","article-title":"Human epicardial adipose tissue cTGF expression is an independent risk factor for atrial fibrillation and highly associated with atrial fibrosis","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.tcm.2025.02.006_bib0023","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2020.07.017","article-title":"Epicardial adipose tissue accumulation confers atrial conduction abnormality","volume":"76","author":"Nalliah","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004095","article-title":"Simultaneous non-invasive epicardial and endocardial mapping in patients with Brugada syndrome: new insights into arrhythmia mechanisms","volume":"5","author":"Rudic","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.006_bib0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.006_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jchf.2020.06.003","article-title":"Epicardial adipose tissue and invasive hemodynamics in heart failure with preserved ejection fraction","volume":"8","author":"Gorter","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006077","article-title":"Influence of sex on the association between epicardial adipose tissue and left atrial transport function in patients with atrial fibrillation: A multislice computed tomography study","volume":"6","author":"Kim","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"10.1016\/j.tcm.2025.02.006_bib0028","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2021.04.003","article-title":"Pericardial fat and the risk of heart failure","volume":"77","author":"Kenchaiah","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.tcm.2025.02.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.020920","article-title":"Regional adiposity and risk of heart failure and mortality: the Jackson Heart Study","volume":"10","author":"Rao","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.02.006_bib0030","article-title":"Epicardial fat modifies the relationship between coronary calcium score and all-cause mortality: the St. Francis Heart Study","volume":"19","author":"Chen","year":"2024","journal-title":"Am J Prevent Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.006_bib0031","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.115.307765","article-title":"Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure","volume":"118","author":"Parisi","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2025.02.006_bib0032","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fphys.2020.00620","article-title":"CD5L, Macrophage apoptosis inhibitor, was identified in epicardial fat-secretome and regulated by isoproterenol from patients with heart failure","volume":"11","author":"Agra-Bermejo","year":"2020","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.tcm.2025.02.006_bib0033","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s44161-022-00032-w","article-title":"Immunometabolic mechanisms of heart failure with preserved ejection fraction","volume":"1","author":"Schiattarella","year":"2022","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0034","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jcmm.14758","article-title":"Proteomics of epicardial adipose tissue in patients with heart failure","volume":"24","author":"Zhao","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-023-02836-4","article-title":"Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain","volume":"21","author":"Choy","year":"2023","journal-title":"BMC Med"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/ejhf.2337","article-title":"Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure","volume":"23","author":"Pugliese","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.006_bib0037","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ejhf.2156","article-title":"Epicardial fat in heart failure with reduced versus preserved ejection fraction","volume":"23","author":"Tromp","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.006_bib0038","article-title":"Mirtazapine reduces adipocyte hypertrophy and increases glucose transporter expression in obese mice","volume":"10","author":"Wu","year":"2020","journal-title":"Animals (Basel)"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.006_bib0039","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ejhf.1283","article-title":"Epicardial fat in heart failure patients with mid-range and preserved ejection fraction","volume":"20","author":"van Woerden","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2025.02.006_bib0040","article-title":"The cardiovascular impact and genetics of pericardial adiposity","author":"Ramo","year":"2023","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.006_bib0041","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4239\/wjd.v14.i6.724","article-title":"Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus","volume":"14","author":"Shi","year":"2023","journal-title":"World J Diabetes"},{"issue":"7","key":"10.1016\/j.tcm.2025.02.006_bib0042","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1152\/ajpendo.00384.2015","article-title":"Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes","volume":"310","author":"Burgeiro","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.tcm.2025.02.006_bib0043","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1042\/CS20210127","article-title":"Lipotoxicity: a driver of heart failure with preserved ejection fraction?","volume":"135","author":"Leggat","year":"2021","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.006_bib0044","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4314\/ahs.v15i2.23","article-title":"Epicardial fat thickness in patients with rheumatoid arthritis","volume":"15","author":"Fatma","year":"2015","journal-title":"Afr Health Sci"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.006_bib0045","first-page":"e60495","article-title":"Epicardial adipose tissue and left ventricular systolic function in rheumatoid arthritis assessed by two-dimensional speckle tracking echocardiography","volume":"16","author":"Wang","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.006_bib0046","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.006_bib0047","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Van Tassell","year":"2014","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2025.02.006_bib0048","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4250\/jcu.2010.18.4.121","article-title":"Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin\/ezetimibe","volume":"18","author":"Park","year":"2010","journal-title":"J Cardiovasc Ultrasound"},{"key":"10.1016\/j.tcm.2025.02.006_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1348913","article-title":"PCSK9 Expression in epicardial adipose tissue: molecular association with local tissue inflammation","volume":"2020","author":"Dozio","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.006_bib0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.repc.2018.08.010","article-title":"Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients","volume":"38","author":"Ziyrek","year":"2019","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0051","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12933-020-01100-w","article-title":"Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis","volume":"19","author":"Halabi","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.006_bib0052","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/dom.14885","article-title":"Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes","volume":"25","author":"Moody","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.tcm.2025.02.006_bib0053","doi-asserted-by":"crossref","first-page":"i610","DOI":"10.1136\/bmj.i610","article-title":"Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies","volume":"352","author":"Li","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.006_bib0054","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/oby.21718","article-title":"Liraglutide causes large and rapid epicardial fat reduction","volume":"25","author":"Iacobellis","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.tcm.2025.02.006_bib0055","doi-asserted-by":"crossref","first-page":"bvz042","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.tcm.2025.02.006_bib0056","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5578216","article-title":"The effect of liraglutide on epicardial adipose tissue in type 2 diabetes","volume":"2021","author":"Zhao","year":"2021","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0057","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00125-019-05021-6","article-title":"Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation","volume":"63","author":"Bizino","year":"2020","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.tcm.2025.02.006_bib0058","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12265-018-9795-z","article-title":"GLP-1 improves diastolic function and survival in heart failure with preserved ejection fraction","volume":"11","author":"Nguyen","year":"2018","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.tcm.2025.02.006_bib0059","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2025.02.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcte.2024.100335","article-title":"SGLT2 inhibitors: beyond glycemic control","volume":"35","author":"Hasan","year":"2024","journal-title":"Journal of Clinical & Translational Endocrinology"},{"key":"10.1016\/j.tcm.2025.02.006_bib0061","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.122.000801","article-title":"Therapeutic potential of targeting prokineticin receptors in diseases","author":"Vincenzi","year":"2023","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.006_bib0062","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2337\/db09-1198","article-title":"Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake","volume":"59","author":"Gardiner","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.006_bib0063","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1476-5381.2012.02191.x","article-title":"Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem","volume":"168","author":"Beale","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.tcm.2025.02.006_bib0064","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12397","article-title":"The Melanocortin receptor accessory protein 2 promotes food intake through inhibition of the prokineticin receptor-1","volume":"5","author":"Chaly","year":"2016","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.tcm.2025.02.006_bib0065","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cmet.2011.01.018","article-title":"Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle","volume":"13","author":"Kubota","year":"2011","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.006_bib0066","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000411","article-title":"Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions","volume":"2","author":"Dormishian","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.02.006_bib0067","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fphys.2020.00425","article-title":"Metformin ameliorates diabetic cardiomyopathy by activating the PK2\/PKR pathway","volume":"11","author":"Yang","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.tcm.2025.02.006_bib0068","article-title":"Prokineticin 2 (PK2) rescues cardiomyocytes from high glucose\/high palmitic acid-induced damage by regulating the AKT\/GSK3beta pathway In vitro","volume":"2020","author":"Yang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.tcm.2025.02.006_bib0069","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/stem.2866","article-title":"A prokineticin-driven epigenetic switch regulates Human epicardial cell stemness and fate","volume":"36","author":"Qureshi","year":"2018","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.tcm.2025.02.006_bib0070","doi-asserted-by":"crossref","first-page":"e81175","DOI":"10.1371\/journal.pone.0081175","article-title":"Prokineticin receptor 1 as a novel suppressor of preadipocyte proliferation and differentiation to control obesity","volume":"8","author":"Szatkowski","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tcm.2025.02.006_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6630102","article-title":"Circulating prokineticin 2 levels are increased in children with obesity and correlated with insulin resistance","volume":"2021","author":"Wang","year":"2021","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.tcm.2025.02.006_bib0072","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molmet.2019.08.016","article-title":"New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: studies in mice and humans","volume":"29","author":"Mortreux","year":"2019","journal-title":"Mol Metab"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.006_bib0073","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1096\/fj.201600181R","article-title":"Prokineticin receptor 1 is required for mesenchymal-epithelial transition in kidney development","volume":"30","author":"Arora","year":"2016","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.006_bib0074","doi-asserted-by":"crossref","first-page":"12804","DOI":"10.1038\/s41598-017-13198-2","article-title":"Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells","volume":"7","author":"Qureshi","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.006_bib0075","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1096\/fj.07-8116com","article-title":"The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis","volume":"21","author":"Urayama","year":"2007","journal-title":"FASEB J"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382500026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382500026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:56:17Z","timestamp":1778795777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017382500026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S105017382500026X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2025.02.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering the role of prokineticin pathway on Epicardial Adipose Tissue (EAT) development and EAT-associated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2025.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}